0001209191-21-002632.txt : 20210107
0001209191-21-002632.hdr.sgml : 20210107
20210107202609
ACCESSION NUMBER: 0001209191-21-002632
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210101
FILED AS OF DATE: 20210107
DATE AS OF CHANGE: 20210107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cappel Markus J.
CENTRAL INDEX KEY: 0001422995
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35420
FILM NUMBER: 21515309
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ChemoCentryx, Inc.
CENTRAL INDEX KEY: 0001340652
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943254365
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650-210-2900
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-01
0
0001340652
ChemoCentryx, Inc.
CCXI
0001422995
Cappel Markus J.
C/O CHEMOCENTRYX, INC.
850 MAUDE AVENUE
MOUNTAIN VIEW
CA
94043
0
1
0
0
Chief Bus. Officer & Treasurer
Common Stock
2021-01-01
4
M
0
6667
0.00
A
82914
D
Common Stock
2021-01-01
4
M
0
6667
0.00
A
89581
D
Common Stock
2021-01-01
4
M
0
7766
0.00
A
97347
D
Common Stock
2021-01-01
4
F
0
11521
61.92
D
85826
D
Restricted Stock Units
2021-01-01
4
M
0
6667
D
Common Stock
6667
0
D
Restricted Stock Units
2021-01-01
4
M
0
6667
D
Common Stock
6667
6667
D
Restricted Stock Units
2021-01-01
4
M
0
7766
D
Common Stock
7766
15534
D
Shares were acquired upon vesting of restricted stock units awarded on March 5, 2018.
Shares were acquired upon vesting of restricted stock units awarded on March 4, 2019.
Shares were acquired upon vesting of restricted stock units awarded on March 3, 2020.
Represents shares withheld upon vesting of restricted stock units to satisfy tax withholding obligation.
Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
The restricted stock units awarded on March 5, 2018, vest in three equal installments on January 1, 2019, January 1, 2020, and January 1, 2021, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date.
The restricted stock units awarded on March 4, 2019, vest in three equal installments on January 1, 2020, January 1, 2021, and January 1, 2022, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date.
The restricted stock units awarded on March 3, 2020, vest in three equal installments on January 1, 2021, January 1, 2022, and January 1, 2023, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date.
/s/ Susan M. Kanaya, as Attorney-in-Fact
2021-01-07